Teva Pharmaceuticals
TEVA
TEVA
452 hedge funds and large institutions have $5.91B invested in Teva Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 160 increasing their positions, 137 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
452
Holders Change
-69
Holders Change %
-13.24%
% of All Funds
9.83%
Holding in Top 10
6
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-53.85%
% of All Funds
0.13%
New
46
Increased
160
Reduced
137
Closed
110
Calls
$255M
Puts
$309M
Net Calls
-$54.5M
Net Calls Change
-$19.6M
Top Buyers
1 |
Renaissance Technologies
New York
|
+$66.1M |
2 |
Morgan Stanley
New York
|
+$47.4M |
3 |
Wellington Management Group
Boston,
Massachusetts
|
+$41M |
4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$37.2M |
5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$32.6M |